Efficacy of ondansetron as antiemetic agent in preventing the incidence of PONV in LSCS under subarachnoid block

Shivanand P.T., Vasantha Kumar J, Ravi R

Abstract


Background: Nausea and vomiting are the most common distressing symptom in the postoperative period. Antiemetic drugs play an important role in therapy of PONV. Though many drugs have been tried as prophylaxis and treatment of PONV, no drug has been proved significantly effective and hence, the present study was undertaken to evaluate the efficacy of prophylactic ondansetron in LSCS patients given spinal anaesthesia.

Methods: After institutional approval and informed consent 100 ASA I & II patients undergoing non emergent LSCS taken for study. The patients were received ondansetron 4mg i.v. 3-5min before surgery. Episodes and severity of nausea, vomiting and retching were noted at the end of 1st, 2nd, 6th and 24th hr.

Results: The mean age, weight and duration of surgery was not significantly different when compared group-A parturiants with group-B. The mean episodes of emesis, nausea and retching at different postoperative duration were significantly decreasing as postoperative time progresses.

Conclusion: The present study suggests that prophylactic ondansetron 4mg is more efficacious in preventing post operative nausea and vomiting in LSCS under spinal anaesthesia.

 


Keywords


LSCS, Ondansetron, Post operative nausea and vomiting, Spinal anaesthesia

Full Text:

PDF

References


Shepherd JA: Simpson and Syme of Edinburgh, Edinburgh, London, E & S Livingstone, 969.

Bhasin SK, Rajoura OP, Sharma AK, et al. A high prevalence of caesarean section rate in East Delhi. Indian J Community Med 2007; 32:222-4.

Nierenberg D, Disch M, Manheimer E, et al. Facilitating prompt diagnosis and treatment of the neuroleptic malignant syndrome. Clin Pharmacol Ther 1991;50(5 Pt 1):580-6.

Hyman N, Manchester TL, Osler T, et al. Anastomotic leaks after intestinal anastomosis: it's later than you think. Ann Surg. 2007 Feb; 245(2):254-8.

Pedersen T. Complications and death following anaesthesia. A prospective study with special reference to the influence of patient-, anaesthesia-, and surgery-related risk factors. Dan Med Bull. 1994 Jun;41(3):319-31.

Watcha MF, White PF. Postoperative nausea and vomiting. Anaesthesiology 1992;77:162-84.

McCaul C, Moran C, O'Cronin D, Naughton F, Geary M, Carton E, et al. Intravenous fluid loading with or without supplementary dextrose does not prevent nausea, vomiting and pain after laparoscopy. Can J Anaesth. 2003;50:440-4.

Bunce KT, Tyers ME. The role of 5-HT in postoperative nausea and vomiting. Br J Anaesth 1992;69:60S5-62S.

Bodner M, White PF. Antiemetic efficacy of ondansetron after outpatient laparoscopy. Anesth Analg 1991;73:250-254.

Chaudhary S, Sethi AK, Motiani P, Adatia C. Pre-operative intravenous fluid therapy with crystalloids or colloids on post-operative nausea and vomiting. Indian J Med Res. 2008; 127:577–81.

Susan Goodina, Regina Cunninghama.5-HT3-Receptor Antagonists for the Treatment of Nausea and Vomiting: A Reappraisal of Their Side-Effect Profile. The Oncologist October 2002;7:424-36.

Pan PH, Moore CH. Comparing the efficacy of prophylactic metoclactic metoclo pramide on placebo in cesarean section patients giving epidural Anesthesia. J Clin Aneath. 2001;13(6):430-5.

Burtles Peerr B. Postoperative vomiting: Some factors affecting its incidence. Br J Anaesth 1957;29:114-23.

McKenzie R, Kovac A, Duncalf D. Comparison of ondansetron versus placebo to prevent postoperative nausea and vomiting in women undergoing ambulatory gynecologic surgery. Anaesthesiology 1993;78:21-28.

Koyama S, Kurita S, Nakatani K, Nagata N, Toyoda Y. Preoperative intravenous of droperidol (1.25 mg) reduced postoperative nausea and vomiting after intrathecal morphine administration. Masui 2011 Feb;60(2):173-9.